Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (351-360 of 408) with videos related to

Pageof 41
Sort By:
Lancet (London, England)|November 17, 2020
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trialJohanne Silvain, Benoit Lattuca, Farzin Beygui, et al.
JACC. Cardiovascular Interventions|September 22, 2022
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial SubstudyGilles Montalescot, Alban Redheuil, Flavien Vincent, et al.
European Heart Journal|March 7, 2018
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on ThrombosisBianca Rocca, Keith A A Fox, Ramzi A Ajjan, et al.
European Heart Journal|May 18, 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trialJean Philippe Collet, Eric Van Belle, Holger Thiele, et al.
Giornale Italiano Di Cardiologia (2006)|August 6, 2019
[2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)]Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 31, 2018
2018 ESC/EACTS Guidelines on myocardial revascularizationMiguel Sousa-Uva, Franz-Josef Neumann, Anders Ahlsson, et al.
Revista Espanola De Cardiologia (English Ed.)|May 22, 2021
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationJean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
European Heart Journal|September 10, 2017
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)Victor Aboyans, Jean-Baptiste Ricco, Marie-Louise E L Bartelink, et al.
Thrombosis and Haemostasis|March 9, 2016
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
European Heart Journal|August 30, 2020
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationJean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
Pageof 41

Showing results (351-360 of 408) with videos related to

Sort By:
Pageof 41
Lancet (London, England)|November 17, 2020
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trialJohanne Silvain, Benoit Lattuca, Farzin Beygui, et al.
JACC. Cardiovascular Interventions|September 22, 2022
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial SubstudyGilles Montalescot, Alban Redheuil, Flavien Vincent, et al.
European Heart Journal|March 7, 2018
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on ThrombosisBianca Rocca, Keith A A Fox, Ramzi A Ajjan, et al.
European Heart Journal|May 18, 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trialJean Philippe Collet, Eric Van Belle, Holger Thiele, et al.
Giornale Italiano Di Cardiologia (2006)|August 6, 2019
[2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)]Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 31, 2018
2018 ESC/EACTS Guidelines on myocardial revascularizationMiguel Sousa-Uva, Franz-Josef Neumann, Anders Ahlsson, et al.
Revista Espanola De Cardiologia (English Ed.)|May 22, 2021
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationJean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
European Heart Journal|September 10, 2017
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)Victor Aboyans, Jean-Baptiste Ricco, Marie-Louise E L Bartelink, et al.
Thrombosis and Haemostasis|March 9, 2016
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
European Heart Journal|August 30, 2020
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationJean-Philippe Collet, Holger Thiele, Emanuele Barbato, et al.
Pageof 41